Literature DB >> 33141517

A Mouse Model of Sublethal Leptospirosis: Protocols for Infection with Leptospira Through Natural Transmission Routes, for Monitoring Clinical and Molecular Scores of Disease, and for Evaluation of the Host Immune Response.

Nisha Nair1, Maria Gomes-Solecki1.   

Abstract

Leptospirosis is a zoonotic disease caused by pathogenic Leptospira species that are maintained in sylvatic and domestic environments by transmission among rodents and other carriers. Humans become infected after contact of breached skin or mucosa with contaminated water or soil. Understanding persistent or sublethal infection in a host is critical for controlling human risk of exposure to pathogenic Leptospira. Animal models that recapitulate disease progression after infection via natural transmission routes are more appropriate for validation of vaccines and therapeutics. Furthermore, the ability to measure shedding of live Leptospira in urine of reservoir and carrier hosts can be used to develop new diagnostic assays and sensors to evaluate human risk of exposure. We developed inbred mouse models of Leptospirosis, that bypass survival as a criterion, in which we can analyze both pathogen and host factors affecting sublethal infection (<1 month), including shedding of Leptospira in urine. Mice are infected with pathogenic Leptospira using a physiologic route, and the clinical, histological, and molecular scores of disease are measured. Furthermore, the host immune response to Leptospira is evaluated. This mouse model also provides a tool in which to test fundamental hypotheses related to host-pathogen interactions and the immune mechanisms engaged in protective and pathogenic immune responses.
© 2020 Wiley Periodicals LLC Basic Protocol 1: Culture and maintenance of virulent Leptospira Basic Protocol 2: Infection of mice through a physiologic route and collection of clinical scores and biological samples Basic Protocol 3: Analysis of pathogenesis after Leptospira infection. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Leptospira; mouse model; natural transmission routes; physiologic route of infection; sublethal leptospirosis

Mesh:

Year:  2020        PMID: 33141517      PMCID: PMC7643393          DOI: 10.1002/cpmc.127

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN: 1934-8525


  28 in total

1.  Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation.

Authors:  S N Vogel; D Johnson; P Y Perera; A Medvedev; L Larivière; S T Qureshi; D Malo
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

Review 2.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

Review 3.  The roles of B cells in MRL/lpr murine lupus.

Authors:  O Chan; M P Madaio; M J Shlomchik
Journal:  Ann N Y Acad Sci       Date:  1997-04-05       Impact factor: 5.691

4.  Host immunological mechanisms in the resistance of mice to leptospiral infections.

Authors:  B Adler; S Faine
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

5.  Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni.

Authors:  Jarlath E Nally; Michael C Fishbein; David R Blanco; Michael A Lovett
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Acute inflammatory response to endotoxin in mice and humans.

Authors:  Shannon Copeland; H Shaw Warren; Stephen F Lowry; Steve E Calvano; Daniel Remick
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

7.  TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans.

Authors:  Cécilia Chassin; Mathieu Picardeau; Jean-Michel Goujon; Pascale Bourhy; Nathalie Quellard; Sylvie Darche; Edgar Badell; Martine Fanton d'Andon; Nathalie Winter; Sonia Lacroix-Lamandé; Dominique Buzoni-Gatel; Alain Vandewalle; Catherine Werts
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

8.  Mouse model for sublethal Leptospira interrogans infection.

Authors:  Luciana Richer; Hari-Hara Potula; Rita Melo; Ana Vieira; Maria Gomes-Solecki
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

9.  Quantification of pathogenic Leptospira in the soils of a Brazilian urban slum.

Authors:  Andrew G Schneider; Arnau Casanovas-Massana; Kathryn P Hacker; Elsio A Wunder; Mike Begon; Mitermayer G Reis; James E Childs; Federico Costa; Janet C Lindow; Albert I Ko
Journal:  PLoS Negl Trop Dis       Date:  2018-04-06

Review 10.  Histological Stains: A Literature Review and Case Study.

Authors:  Hani A Alturkistani; Faris M Tashkandi; Zuhair M Mohammedsaleh
Journal:  Glob J Health Sci       Date:  2015-06-25
View more
  4 in total

1.  Role of TLR4 in Persistent Leptospira interrogans Infection: A Comparative In Vivo Study in Mice.

Authors:  Nisha Nair; Mariana S Guedes; Adeline M Hajjar; Catherine Werts; Maria Gomes-Solecki
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

2.  Enzyme immunoassays (EIA) for serodiagnosis of human leptospirosis: specific IgG3/IgG1 isotyping may further inform diagnosis of acute disease.

Authors:  Elsa Fortes-Gabriel; Mariana Soares Guedes; Advait Shetty; Charles Klazer Gomes; Teresa Carreira; Maria Luísa Vieira; Lisa Esteves; Luísa Mota-Vieira; Maria Gomes-Solecki
Journal:  PLoS Negl Trop Dis       Date:  2022-02-23

3.  Transient Presence of Live Leptospira interrogans in Murine Testes.

Authors:  Advait Shetty; Suman Kundu; Frédérique Vernel-Pauillac; Gwendoline Ratet; Catherine Werts; Maria Gomes-Solecki
Journal:  Microbiol Spectr       Date:  2022-04-21

4.  Hematogenous dissemination of pathogenic and non-pathogenic Leptospira in a short-term murine model of infection.

Authors:  Matthew C Surdel; Phillip N Anderson; Beth L Hahn; Jenifer Coburn
Journal:  Front Cell Infect Microbiol       Date:  2022-07-18       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.